(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

JOULIXXI

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

JOULIXXI

ST13

US500000097488468

Class

5

Filing

97488468

Registration

7292961

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

20

Latest update

12/21/2024

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

07/05/2022

Registration date

01/30/2024

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/30/2024

Last transaction

12/21/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

4

Owner type

99

Owner location

Leverkusen, DE

Examiner

DINALLO, KEVIN

Law office

L70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

B. A. (pessoa física)

Representatives

Phillip Barengolts Pattishall, McAuliffe, Newbury, Hilliard & Geraldson LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for humans for treatment of gynecological related diseasesdisorders and deficiencies; Pharmaceutical preparations for humans for treatment of hormone related diseasesdisorders and deficiencies; Pharmaceutical preparations for humans for treatment of cardiological related diseasesdisorders and deficiencies; Pharmaceutical preparations for humans for treatment of oncological related diseasesdisorders and deficiencies; Pharmaceutical preparations for humans for treatment of genetic related diseasesdisorders and deficiencies

Publications

History of USPTO decisions and trademark events.

20 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/17/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/17/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/17/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/30/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

01/30/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/14/2023

PUBO

PUBLISHED FOR OPPOSITION

11/14/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/25/2023

FIXD

ELECTRONIC RECORD REVIEW COMPLETE

10/12/2023

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

10/06/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/05/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/04/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/04/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/28/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/20/2023

GNRT

NON-FINAL ACTION E-MAILED

04/20/2023

CNRT

NON-FINAL ACTION WRITTEN

04/20/2023

DOCK

ASSIGNED TO EXAMINER

04/19/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/23/2022

NWAP

NEW APPLICATION ENTERED

07/08/2022

Continuous trademark protection

Get notified about every new filing that threatens JOULIXXI or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.